Skip to main content

Table 3 Baseline and follow-up clinical characteristics in the remission group and non-remission group

From: The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China

Characteristic Remission (n = 104) Non-Remission (n = 82) P
Baseline    
 Age at biopsy (years) 47.7 ± 13.0 50.8 ± 13.8 0.120
 Male (n, %) 44 (42.3) 60 (73.1)  < 0.001
 SCr (μmol/L) 64.8 ± 22.1 74.0 ± 22.1 0.006
 eGFR (ml/min/1.73m2) 103.8 ± 20.5 97.0 ± 20.5 0.025
 Urea (mmol/L) 5.2 ± 2.0 6.0 ± 2.3 0.017
 Alb (g/L) 31.0 ± 24.7 25.1 ± 6.2 0.038
 UA (μmol/L) 365.1 ± 104.9 368.0 ± 92.7 0.871
 24 h-u-pro (g/d) 4.05 (1.97,6.31) 4.28 (2.49,8.66) 0.059
 Hypertension (n, %) 30 (28.8) 22 (26.8) 0.761
Follow-up    
 SCr (μmol/L) 68.4 ± 18.8 122.8 ± 126.6  < 0.001
 eGFR (ml/min/1.73 m2) 100.0 ± 20.1 77.1 ± 35.3  < 0.001
 Urea (mmol/L) 5.5 ± 1.9 8.0 ± 4.0  < 0.001
 Alb (g/L) 41.1 ± 5.17 30.4 ± 8.24  < 0.001
 UA (μmol/L) 358.5 ± 95.1 392.8 ± 118.1 0.037
 24 h-u-pro (g/d) 0.23 (0.76,1.05) 3.01 (2.06,7.95)  < 0.001